ABSTRACT -Depression is one of the frequently-observed psychiatric symptoms associated with nicotine (NC) use. In the present study, considering the unique effects of NC (e.g. antidepressant effects have also been reported), the time course of the NC-induced depressive behavioral alterations in a mouse model was compared with a typical depression-inducing stressor. Furthermore, based on the involvement of cannabinoid (CB) receptors in the behavioral effects of NC, the effects of antidepressants including CB ligands (CBs) against the NC-induced behavioral alterations were also investigated. Repeated subcutaneous NC treatments (0.3 mg/kg, 4 days), like repeated immobilization stress (IM) treatments (10 min, 4 days), caused prolonged depressive effects (increased immobility time) at both 2 hr and 1 day time points after the last treatment in the tail suspension test. However, in the NC group, depressive effects (suppressed swimming behaviors) were observed only at the 2 hr time point in the forced swimming test 
INTRODUCTION
Depression is one of the frequently-observed behavioral symptoms associated with nicotine (NC) use (West et al., 1989; Lerman et al., 1996; Parrott, 2004) . NCinduced depression has been reported mainly as a withdrawal symptom which occurs after repeated use (West et al., 1989; Lerman et al., 1996) . Furthermore, direct depressive effects induced by NC, which disappear soon after the cessation of smoking, have also been reported in clinical cases (Parrott, 2004) . However, depending on the conditions of clinical research in humans and on experimental models in animals, antidepressant effects which may reinforce its habitual use have also been reported for NC (Hawkins, 1997; Tizabi et al., 1999; Vazquez-Palacios et al., 2004; Slawecki et al., 2005) . The occurrence of both depressive and antidepressant symptoms seems to be one of the characteristics of NC-induced depression-related behavioral symptoms.
In some animal models, NC-induced depressive behavioral alterations were demonstrated as exacerbated immobility in behavioral tests such as forced swimming test (Mannucci et al., 2006; Hayase, 2007) . This test is used for screening antidepressants, which suppress immobility in swimming behaviors (Porsolt et al., 1977) . On the other hand, various physical stressors, which are considered to cause depressive effects, exacerbate immobility in swimming behaviors (Armario et al., 1991) . Therefore, NC can be regarded as a stressor similar to these "depressive stressors".
The mechanisms underlying NC-induced depressionrelated behavioral alterations can be differentiated from other depressive behaviors, because brain nicotinic acetylcholine receptors (nAChRs), which have been reported to contribute greatly to depressed behaviors (Shytle et al., 2002; Tritto et al., 2004) , are the direct targets of NC. Close functional interactions between nAChRs and monoamine neurons, the targets of clinically used antidepressants, have been demonstrated by experiments modifying nAChRs by inhibiting monoamine reuptake (Lopez-Valdes and Garcia-Colunga, 2001 ). Therefore, it is possible that clinically-used antidepressants such as brain monoamine reuptake inhibitors are effective against these NC-induced depressive behavioral alterations. On the other hand, it is predicted that brain neurons other than nicotinic acetylcholine (nACh) neurons are also modified characteristically by NC, as suggested previously (Yu and Wecker, 1994) , and contribute to behavioral effects of NC. Brain cannabinoid (CB) neurons are among the neurons interacting closely with NC; for example, the amount of endogenous CB ligands (cannabinoids et al., 2002) . Furthermore, NC-induced behavioral responses receptors (Castañé et al., 2002) . Antidepressant effects or the altered amount of some endogenous CBs (Jiang et al., 2005; Gobbi et al., 2005; Bambico et al., 2007) .
In the present experiment, using two behavioral tests in mice (forced swimming and tail suspension tests), NCinduced depression-related behavioral alterations were investigated and compared with the depressive behaviors caused by typical stressor immobilization stress (IM). Furthermore, the effects of antidepressants including CBs were examined.
MATERIALS AND METHODS

Animals
Male ICR mice (60-90 days old) (Shizuoka Laboratory Animal Center, Hamamatsu, Japan) were housed in a forcedair facility, which was maintained at 23°C and 50% relative humidity, with a 12 hr/12 hr light/dark cycle (Boyer and Petersen, 1992; Hayase et al., 2000) . The mice were kept separately in single transparent cages measuring 23.5 × 16.5 × 12 cm, and were allowed water and rodent chow ad libitum (Boyer and Petersen, 1992; Hayase et al., 2000) . The experiments described in this report were conducted in accordance with the "Guidelines for Animal Experiments" of our institution (1988) , which are based on the National Institutes of Health Guide for Care and Use of Laboratory Animals, and any pain experienced by the mice was minimized. For the mouse behavioral experiments, all of the observations and evaluations were performed by a trained observer who was blinded to the treatment conditions and had not been informed of the treatment conditions in advance. Each experimental group contained 7 mice.
Drug and stressor treatments
The protocols for the NC and stressor treatments were determined based on preliminary experiments and previous studies examining its behavioral effects (Armario et al., 1991; Hayase et al., 2000; Hayase, 2007) . With respect to the NC treatment, repeated subcutaneous (s.c.) doses of NC which caused depressive behaviors most effectively were selected: a single s.c. dose of 0.3 mg/kg was administered daily for 4 days (Hayase, 2007) . NC (Nacalai Tesque, Inc., Kyoto, Japan), which was supplied in the free-base form at 95 % purity, was freshly dissolved in saline to a volume of 5 ml/kg immediately before each administration. With respect to the stressor treatment, treatments using IM, which have been demonstrated to cause depressive effects, were adopted based on previous studies in rodent depression models (Hayase et al., 2000) . In the present experiments, repeated treatments of IM in which the peak effects were almost equivalent to the NC treatments in preliminary experiments were selected: 10 min of IM, which was induced by placing the mouse in a narrow space (diameter about 12 cm) in a vinyl bag with some breathing holes, was given daily for 4 days.
The antidepressants except for CBs were selected from those drugs which acted as antidepressants in rodent depression models in preliminary experiments and previous studies (Consoli et al., 2005; Ushijima et al., 2005) . The drugs selected were the monoamine reuptake inhibitors amitriptyline (amitriptyline hydrochloride (AT)) purchased from Banyu Pharmaceutical Co., Ltd. (Tokyo, Japan), clomipramine (clomipramine hydrochloride (CL)) purchased from Ciba-Geigy Ltd. (Takarazuka, Japan), and Tocris Cookson Inc. (Ellisville, MO, USA).
As CBs, those drugs which are predicted to act on brain CB receptors were administered. Therefore, the endogenous CBs anandamide (arachidonylethanolamide (AEA)) and virodhamine (VD), the synthetic agonist CP 55940 ((-)-cis-3-[2-Hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol) (CP), the synthetic antagonist AM 251 (N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide) (AM), and synthetic AEA-like ligand O-2093 (N-N'-di-(3-chloro-4-hydroxy) benzyl-arachidonamide), all purchased from Tocris Cookson Inc., were selected (Devane et al., 1988; Felder et al., 1993; Di Marzo et al., 2002; Porter et al., 2002; McLaughlin et al., 2003) .
With respect to the doses of antidepressants and CBs, the doses for the repeated administrations were selected after preliminary experiments examining a broad range of concentrations. For each drug, data were collected and shown for a dose which induced no depressionrelated behavioral alterations by itself at the selected time point, but which provided the most effective antidepressant effects (if any). An intraperitoneal (i.p.) injection of the selected dose of each drug was then performed repeatedly before each NC or IM treatment. Except for the CBs, the antidepressants were administered 15 min before each NC or IM treatment, whereas the CBs were administered 60 min before each NC or IM, based on previous studies and preliminary experiments (Van Dijken et al., 1992; Romero et al., 1995) .
Since the CBs are not soluble in water, they were initially dissolved in dimethylsulphoxide (DMSO) (Nacalai Tesque Inc.) to one-third of the total volume, and then diluted in distilled water to a volume of 5 ml/kg. Since AEA, VD and O-2093 were provided in ethanol solutions (Tocris Cookson Inc.), the ethanol was evaporated immediately before use under nitrogen gas, and the residues were initially dissolved in DMSO to one-third of the total volume, and then diluted in distilled water to a volume of 5 ml/kg (Compton and Martin, 1997; Costa et al., 2000) . The other antidepressants were also dissolved or diluted in DMSO to one-third of the total volume, and then diluted in distilled water to a volume of 5 ml/kg. In the NCand IM-only groups, even for the time course study of the NC-only treatment, a mixed vehicle solution of DMSO and distilled water at the same ratio as the solutions of antidepressants or CBs was injected instead of the i.p. injection of the antidepressants or CBs, 15 min before each NC or IM treatment. In the antidepressant-and CBonly groups, the same volumes of saline vehicle were injected instead of the s.c. injection of NC. In the control group without any drug or stressor treatment (control group), a control vehicle solution of DMSO and distilled water at the same ratio as the antidepressant or CB solutions was injected instead of the antidepressants or CBs, and then the same volume of saline vehicle was injected instead of the NC or IM treatment. The drug and stressor treatments and each experimental session were performed between 15 and 19 hr light cycle.
Forced swimming test
Based on previous studies (Porsolt et al., 1977; Hayase et al., 2000) , a glass cylinder apparatus 33 cm in height and 18 cm in diameter containing 14 cm of water at 21-23°C was used for the forced swimming test. As parameters for the test, the time until immobility (the time after when only modest swimming behaviors necessary to avoid drowning were observed) and the activity counts for 10 min yielded by the swimming behaviors were evaluated. In the time course study, evaluations of these parameters were performed at the 2 hr and 1 day time points after NC or IM treatment, for different groups of mice at each time point. The activity was counted using the activitymeasuring and recording system Supermex-CompACT AMS instrument (Muromachi Kikai Co. Ltd., Tokyo, Japan) by placing the sensor of the instrument over the cylinder at a distance of 20 cm from the water.
Tail suspension test
Based on previous studies (Steru et al., 1985) , a cardboard cube apparatus with one side of 35 cm was used for the tail suspension test. The front surface of the apparatus tail in the center of the upper surface using a tail hanger and non-irritating adhesive tape. As a parameter for the test, the total duration of immobility (total immobility time) during the 6 min experimental period was calculated. In the time course study, evaluations of the parameters were performed at the 2 hr and 1 day time points after the NC or IM treatment, for different groups of mice at each time point.
Statistical analysis
The data obtained were subjected to two-way analysis of variance (ANOVA) (Alves et al., 2004; Hayase, 2007) . In the experiments on the time course of the NCinduced behavioral alterations, a 3 (NC, IM versus vehicle) × 2 (2 hr versus 1 day) factorial design was used for the factors NC or IM treatment × test time. In the experiments on the effects of antidepressants or CBs, a 3 (NC, IM versus vehicle) × 9 (AT, CL, FL, AEA, VD, CP, AM, O-2093 versus vehicle) factorial design was used for the factors NC or IM treatment × treatment of each antidepressant or CB drug. The results from the ANOVA analyses are summarized in Table 1 . For pairwise comparisons, post-hoc Bonferroni tests were performed (Alves et al., 2004; Hayase, 2007) . All of the comparisons were performed using statistical software packages ("Excel Statistics" from Social Survey Research Information Co. Ltd. Inc., Tokyo, Japan). Unless otherwise noted, P values less
RESULTS
Time course of NC-and IM-induced depressive behavioral alterations in the forced swimming test
In both NC and IM groups, at the 2 hr time point, depressive behavioral alterations in swimming behaviors, i.e. significantly attenuated times until immobility (Fig. 1a) and attenuated activity counts (Fig. 1b) , were observed for all parameters in the forced swimming test. In the NC group, all of the altered parameter values returned to the control levels at the 1 day time point. However, in the IM group, depressive alterations in the swimming behaviors were observed at both 2 hr and 1 day time points.
The ANOVA (Table 1a ) revealed significant main effects of the NC or IM treatment for each parameter valeffects of test time and interactions between the NC or IM treatment and the test time were also observed, which indicated some time-dependent changes.
Time course of NC-and IM-induced depressive behavioral alterations in the tail suspension test
In both NC and IM groups, at both 2 hr and 1 day time increases in the total immobility time, were observed in the tail suspension test (Fig. 2) . The ANOVA (Table 1a ) revealed significant main effects of the NC or IM treatment.
Effects of antidepressants or CBs against NCand IM-induced depressive behavioral alterations in the forced swimming test
The effects of the antidepressants or CBs were examined at the 2 hr time point after the last NC or IM treatment, and the data for the doses selected in the aboveexplained way (10 mg/kg for the drugs except for CP or 2.5 mg/kg for CP) are shown in Fig. 3 . For the NC group, in those groups co-treated with the CBs, VD and O-2093, significant recoveries from the depressive behavioral alterations (i.e. recoveries from the attenuated times until immobility and attenuated activity counts) to the control levels were observed for each parameter. For the IM group, in those groups co-treated with the antidepressants AT, CL, and FL as well as the CBs, VD and O-2093, sig--tions to the control levels were observed for each parameter value. With respect to those groups co-treated with AT, CL, and FL, all values in the NC group tended to be decreases were observed for the activity counts. No significantly different effects were observed between the monoamine reuptake inhibitors AT, CL, and FL, although the rank of selectivity for serotonin is FL > CL > AT (Brocco et al., 2002) . In each antidepressant-or CB-only were observed (Table 2 ).
The ANOVA (Table 1b ) revealed significant main effects of the NC or IM treatment for each parameter valeffects of the antidepressants or CBs treatment and interactions between NC or IM treatment and antidepressants or CBs treatment were also observed, which indicated some IM-induced depression-related behavioral alterations.
Effects of antidepressants or CBs against NCand IM-induced depressive behavioral alterations in the tail suspension test
The effects of the antidepressants or CBs were examined at the 2 hr time point after the last NC or IM treatment, and the data for the dose selected in the aboveexplained way (10 mg/kg for the drugs except for CP or 2.5 mg/kg for CP) are shown in Fig. 4 . For both NC and IM treatment groups, in the groups co-treated with the antidepressants AT, CL and FL as well as the CBs, VD and -ioral alterations (i.e. recovery from the increased total immobility time) to the control levels were observed. No monoamine reuptake inhibitors AT, CL and FL. In each -tions in each parameter value were observed ( Table 2) .
The ANOVA (Table 1b ) revealed significant main effects of the NC or IM treatment and the antidepres--tions between NC or IM treatment and antidepressants or CBs treatment were also observed, which indicated some IM-induced depression-related behavioral alterations.
DISCUSSION
The present experiments demonstrated the occurrences and continuations of NC-induced "depressive" effects in the forced swimming and tail suspension tests. Like the groups of mice treated with IM, a typical stressor which induces depressive effects, both suppressed swimming behaviors in the forced swimming test and increased immobility time in the tail suspension test were observed in the NC group under the present conditions. However, antidepressant effects have also been demonstrated for NC in other animal models (Tizabi et al., 1999; VazquezPalacios et al., 2004; Slawecki et al., 2005) . The investigation of those NC treatment animal models, in which antidepressant effects were predominantly observed, has revealed that the appearance of depressive versus antidepressant effects seemed to be controlled by the treatment conditions, such as the dose, number of administrations, time after use, previous exposure to NC, etc., which suggests a complicated mechanism underlying the effects of NC (Tizabi et al., 1999; Vazquez-Palacios et al., 2004; Slawecki et al., 2005) . In previous studies, even repeated doses of subcutaneous NC (less than 0.5 mg/kg for less than 15 days), such as a single dose of NC, caused antidepressant effects at early time points (within 15 min) after the last NC treatment (Tizabi et al., 1999; Vazquez-Palacios et al., 2004; Slawecki et al., 2005) . This is consistent with the preliminary unpublished data of the author. On the other hand, with respect to the NC-induced depressive behavioral alterations in mouse experimental models, withdrawal depressive behaviors were observed after the 15-day time point following NC treatments of more than 0.5 mg/kg per day for at least 15 days (Mannucci et al., 2006) , but the detailed time course before the 1 day time point has not been studied. In the present mouse experimental model, depressive behaviors were observed before and/or at the 1 day time point after repeated NC treatments for 4 days. Although the mechanisms underlying the appearance of these dual contrary behavioral -sympathoadrenal system, increased stress hormones, etc.) have been reported to accompany NC treatment, and seem to be affected by differing conditions such as the number of NC administrations (Kirch et al., 1987; Morse, 1989; Sun et al., 2003) . Furthermore, the time course of those of these dual behavioral effects.
Between the NC and IM groups, there were some differences in the time courses and in terms of the drugs which antagonized these "depressive" effects. One of the characteristics of the NC group is that, unlike the IM group, prolonged depressive effects at the 1 day time point were not detected in the forced swimming test (Fig.  1) . On the other hand, in the tail suspension test, prolonged depressive behavioral symptoms were observed in both NC and IM groups. The absence of prolonged depressive effects for NC in the forced swimming test seems to be correlated with the mechanisms underlying the suppressed swimming behaviors. Depression-relat- ed behavioral reactions seem to be mediated by a number of neuronal mechanisms activated by various stressors. Furthermore, regardless of the type of stressors, the relative contribution of each mechanism may be different between the forced swimming and tail suspension tests. Therefore, it was hypothesized that the NC-induced neu--ations in the forced swimming test, would continue for a shorter time as compared to the IM-induced neuronal modifications. Although the detailed neuronal modifications correlated with the NC-suppressed swimming behaviors have not been elucidated, nAChR-mediated alterations in dopamine levels, etc.), which can be caused characteristically by NC, have been demonstrated (Tani et al., 1997) . Furthermore, even without any drug or stressor treatments, behavioral alterations during the forced swimming test, unlike the tail suspension test, have been reported to be accompanied immediately by rapid alterations in the brain monoamine levels (Renard et al., 2003) . These characteristic alterations in the monoamine system Values represent means ± S.D. (n = 7 for each group). Vol. 33 No. 5 give rise to the shorter duration of depressed swimming behaviors in the NC group as compared to the IM group. Against the NC-induced depressive behavioral alterations, significant antagonistic effects were provided by some antidepressants which inhibit the reuptake of monoamines and several CBs. However, unlike the IM group, the antidepressant drugs which inhibit the reuptake of monoamines (AT, CL, and FL) were not significantly effective in the NC group in the forced swimming test for these drugs could not be predicted based on the previous data and suggested a contribution of the monoamine system to the depression-related behavioral alterations in both forced swimming and tail suspension tests (Steru et al., 1985; Rénéric et al., 1998; Fujishiro et al., 2001) . Nevertheless, considering the characteristic NC--tem in the forced swimming test, which include the alterations in dopamine levels (Tani et al., 1997; Renard et al., 2003) , there seems to be a possibility that the antidepressants such as AT, CL and FL, which inhibit mainly the reuptake of noradrenaline and 5-hydroxy-tryptamine (5-HT), cannot antagonize effectively the NC-induced depressive swimming behaviors, at least during the test time, as compared to the other "antidepressant" drugs.
Among the CBs, in both NC and IM groups, only the mixed agonistic/antagonistic endocannabinoid VD (Porter et al., 2002) and the AEA-like cannabimimetic O-2093 (Di Marzo et al.
sant effects. On the other hand, the other CBs, which have been reported to function as pure agonists (AEA, CP, etc.) or antagonists (AM etc.) on brain CB receptors (Devane et al., 1988; Felder et al., 1993; McLaughlin et al., 2003) , did not provide any antidepressant effects. VD has been reported to provide agonistic effects on brain CB receptors when administered alone, but has also been reported to attenuate the effects of other agonistic drugs such as AEA (Porter et al., 2002) . O-2093 has been reported to provide behavioral effects similar to AEA (e.g. hypolocomotion, antinociception, hypothermia, etc.), but has brain CB receptors which interact with AEA (Di Marzo et al., 2002) . Based on the observed effects of VD, it can be hypothesized that the mixture of agonistic and antagonistic effects on brain CB receptors, but not pure agonistic effects, was favorable for blocking the depressive effects. However, based on the previous literature on O-2093 (Di Marzo et al., 2002 and the present results, the interact with O-2093 is suspected. Furthermore, it is pos-VD. Although the CB-related mechanisms underlying the -ciently, the present results strongly support the presence of diverse neuronal mechanisms contributing to this phenomenon.
In conclusion, the present results demonstrated that the depressive effects of NC are similar to the effects of a typical depression-inducing stressor in two representative behavioral tests. In the tail suspension test, prolonged depressive effects which support the risk of repeated NC use were observed. The shorter duration of the behavioral alterations in the forced swimming test as compared peculiar to NC, which were not antagonized by those antidepressants which inhibit the reuptake of monoamines. Some clinical studies have reported that NC induced a long-lasting depression for mainly withdrawal cases after repeated NC use (West et al., 1989; Lerman et al., 1996) . The present study, using an animal model, adds more data on the NC-induced depressive behavioral alterations after a relatively small number of repeated NC administrations (4 days), which warns of the risk of NC use. Furthermore, considering the "antidepressant" effects of the atypical CBs, VD and O-2093 against the NC-induced depressive behaviors, one can predict that the characteristic effects as a mixed CB agonist/antagonist and/or the involvement
